The Ruth and Raymond Perelman Center for Advanced Medicine is a specialized medical facility located at 34th Street and Civic Center Boulevard, on the former site of the Philadelphia Civic Center, on the campus of the Hospital of the University of Pennsylvania.

During the past decade, University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine" are "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Non-Small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine" in a lesser frequency.

Most popular intervention types in "University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lazertinib" (3 trials), "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Pemetrexed" (2 trials) and "Amivantamab Intravenous" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine" are 3 trials for "All" genders.

Currently, there are NaN active trials in "University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".